Retatrutide is a new treatment in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these receptors, https://royytcm624692.blogadvize.com/44069504/tirzepatide-a-promising-new-treatment-for-obesity